BioCryst Pharmaceuticals | Ativos

Assets Alterar Data
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
BioCryst Pharmaceuticals USD 522.92M 6.96M 2023-09
Chugai Pharma JPY 1.82T 13.94B 2023-09
Daiichi Sankyo JPY 2.65T 33.03B 2023-09
Enanta Pharmaceuticals USD 462.28M 32.89M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Incyte USD 6.78B 393.87M 2023-12
Intra Cellular Therapies USD 728.3M 10.63M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Novavax USD 1.66B 27.89M 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



BioCryst Pharmaceuticals Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.